The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 77.43%. However, over the last six months, the performance has been weaker by 60.10%. The price of BLU increased 1.07% over the last 30 days. And in the last five days, it has surged by 1.00%.
BELLUS Health Inc. (BLU) current stock price is $14.59. During the last trading session, the stock soared, reaching $14.49 after opening at $14.49. The stock’s lowest point was $14.445 before it closed at $14.45.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The stock market performance of BELLUS Health Inc. has been very steady. Over the last year, the company’s stock hit its highest at $14.54 on 05/23/23, while the lowest price during the same time frame was $6.38, recorded on 04/05/23.
52-week price history of BLU Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. BELLUS Health Inc.’s current trading price is 0.31% away from its 52-week high, while its distance from the 52-week low is 128.61%. The stock’s price range for this period has been between $6.38 and $14.54. The Healthcare sector company’s shares saw a trading volume of about 2.65 million for the day, which was lower than the average daily volume of 4.51 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
BELLUS Health Inc. (BLU) has experienced a quarterly rise of 93.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.83B and boasts a workforce of 74 employees.
Expert Opinions: Analysts’ Ratings for BELLUS Health Inc.
As of right now, 6 analysts are rating BELLUS Health Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.43, with a change in price of +6.23. Similarly, BELLUS Health Inc. recorded 3,074,741 in trading volume during the last 100 days, posting a change of +74.61%.
BLU’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for BLU stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BLU Stock Stochastic Average
As of today, the raw stochastic average of BELLUS Health Inc. over the last 50 days is at 99.82%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 94.74%. Further, the company’s Stochastic %K and %D values for the last 20 days were 67.81% and 58.35%, respectively.